Sareum HoldingsFRA:RYH0 37 EV-to-FCF is -7.95 as of Jul. 06, 2026. GuruFocus rates FRA:RYH0 with a GF Score™ of 37/100. The stock has 3 warning signs investors should review. Among 330 Biotechnology companies, Sareum Holdings ranks worse than 303030% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Sareum Holdings's Enterprise Value is €30.85 Mil.
Sareum Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-3.88 Mil. Therefore, Sareum Holdings's EV-to-FCF for today is -7.95.
The historical rank and industry rank for Sareum Holdings's EV-to-FCF or its related term are showing as below:
FRA:RYH0'
s EV-to-FCF Range Over the Past 10 Years
Min: -331.84 Med: -46.86 Max: -5.91
Current: -7.96
During the past 13 years, the highest EV-to-FCF of Sareum Holdings was -5.91. The lowest was -331.84. And the median was -46.86.
FRA:RYH0's EV-to-FCF is ranked worse than 100% of 330
companies
in the Biotechnology industry
Industry Median: 16.3
vs FRA:RYH0: -7.96
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Sareum Holdings's PE Ratio (TTM) for today is calculated as:
Sareum Holdings's share price for today is €0.198.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sareum Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was €-0.046.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Sareum Holdings EV-to-FCF Related Terms
Sareum Holdings EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Sareum Holdings's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:RYH0 vs VRTX, REGN, ALNY: EV-to-FCF Comparison
For the Biotechnology subindustry, Sareum Holdings's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sareum Holdings EV-to-FCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Sareum Holdings's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Sareum Holdings's EV-to-FCF falls into.
Sareum Holdings's current Enterprise Value is €30.85 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Sareum Holdings's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was €-3.88 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sareum Holdings (FRA:RYH0) has a EV-to-FCF of -7.95 as of Jul. 06, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sareum Holdings and its competitors. According to the industry distribution chart, Sareum Holdings ranks #999999 out of 330 companies in the Biotechnology industry.
Is Sareum Holdings' EV-to-FCF too high?
Sareum Holdings' current EV-to-FCF is -7.95. Based on the distribution chart, Sareum Holdings ranks #999999 out of 330 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Sareum Holdings has a GF Score™ of 37/100, reflecting its overall financial health beyond just this single metric.
How does Sareum Holdings' EV-to-FCF compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Sareum Holdings ranks #999999 out of 330 companies for EV-to-FCF. This places Sareum Holdings in the lower half of its industry. The industry median EV-to-FCF is 16.30. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Biotechnology company?
The median EV-to-FCF among Biotechnology companies is 16.30, based on 330 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Sareum Holdings and its competitors. For the Biotechnology industry, the median EV-to-FCF is 16.30 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sareum Holdings's current EV-to-FCF is -7.95. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sareum Holdings stock overvalued right now?
Sareum Holdings (FRA:RYH0) has a current EV-to-FCF of -7.95. The current EV-to-FCF is -7.95. Sareum Holdings' overall GF Score™ is 37/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Sareum Holdings (FRA:RYH0), the current EV-to-FCF is -7.95 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sareum Holdings PLC is engaged in drug discovery and development. The company is focused on cancer and autoimmune diseases and licensing them to pharmaceutical and biotechnology companies. The company's drug pipeline includes SDC-1801 for autoimmune diseases, SDC-1802 for cancers, SRA737 targeting solid tumors among others.
37GF Score
Get the complete analysis for FRA:RYH0
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:RYH0 has been successfully added to your 
